Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice

Vedantham, Vasumathy; Kim, Ramasamy
June 2006
Indian Journal of Ophthalmology;Jun2006, Vol. 54 Issue 2, p133
Academic Journal
journal article
Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients. Laser photocoagulation, which is the standard treatment of macular edema, is associated with significant complications and an improvement in visual acuity is unsatisfactory. Intravitreal injection of corticosteroids (especially triamcinolone acetonide) is an emerging treatment modality in the management of diabetic macular edema. This article presents an overview of the principles, technique and complications associated with this procedure.


Related Articles

  • Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Paccola, L.; Costa, R. A.; Folgosa, M. S.; Barbosa, J. C.; Scott, I. U.; Jorge, A. // British Journal of Ophthalmology;Jan2008, Vol. 92 Issue 1, p76 

    Background/aims: The aim of this study was to compare the morphological and visual acuity outcomes associated with a single intravitreal injection of triamcinolone acetonide versus bevacizumab for the treatment of refractory diffuse diabetic macular oedema. Methods: Twenty-eight patients were...

  • Intravitreal Triamcinolone in Diabetic Retinopathy. Abraldes, Maximino J.; Fernández, Maribel; Gómez-Ulla, Francisco // Current Diabetes Reviews;2009, Vol. 5 Issue 1, p18 

    Diabetic macular edema is an important cause of visual loss in the developed world and may frequently lead to irreversible changes in visual acuity. The Early Treatment Diabetic Retinopathy Study showed a significant benefit in using focal laser photocoagulation for the treatment of macular...

  • Recurrence of choroidal neovascularisation after photodynamic therapy in patients with age-related macular degeneration. Potter, Michael J.; Szabo, Shelagh M. // British Journal of Ophthalmology;Jun2007, Vol. 91 Issue 6, p753 

    Aim: To determine the incidence of recurrence of choroidal neovascularisation (CNV) 18 months after cessation of photodynamic therapy (PDT) with verteporfin monotherapy in patients with age-related macular degeneration (AMD). Methods: This was a prospective interventional cohort study. The...

  • Causes and 3-year-incidence of blindness in Jing-An District, Shanghai, China 2001-2009. Liangcheng Wu; Xinghuai Sun; Xingtao Zhou; Chenghai Weng // BMC Ophthalmology;2011, Vol. 11 Issue 1, p10 

    Background: Registered data can provide valuable information regarding blindness. The purpose of this study was to evaluate the main causes and 3-year incidence of registered blindness in Jing-An district in Shanghai, China. Methods: Data from the blindness registry (age, gender and cause of...

  • Role of Inflammation in the Pathogenesis of Diabetic Retinopathy. Abu El-Asrar, Ahmed M. // Middle East African Journal of Ophthalmology;Jan-Mar2012, Vol. 19 Issue 1, p70 

    Diabetic retinopathy (DR) remains a major cause of worldwide preventable blindness. The microvasculature of the retina responds to hyperglycemia through a number of biochemical changes, including activation of protein kinase C, increased advanced glycation end products formation, polyol pathway,...

  • Pycnogenol® Improves Microcirculation, Retinal Edema, and Visual Acuity in Early Diabetic Retinopathy. Steigerwalt, Robert; Belcaro, Gianni; Cesarone, Maria Rosaria; Di Renzo, Andrea; Grossi, Maria Giovanna; Ricci, Andrea; Dugall, Mark; Cacchio, Marisa; Schönlau, Frank // Journal of Ocular Pharmacology & Therapeutics;Dec2009, Vol. 25 Issue 6, p537 

    Purpose: The growing numbers of diabetes cases in the developed world are followed by increasing numbers of people diagnosed with diabetic complications. Diabetic microangiopathies in the eye lead to the development of retinopathy involving gradual loss of vision. Previous studies with...

  • Visual Fields Refine Understanding of Diabetic Retinopathy Progression. Jackson, Gregory R.; Gardner, Thomas W. // Diabetes;Sep2014, Vol. 63 Issue 9, p2909 

    The article focuses on a study which examined the effect of diabetes on the neural retina. Topics discussed include the finding that deterioration of the neural retina may take place for years without a clinically detectable change in the microvasculature, and evidence showing that diabetic...

  • Transcutaneous Electrical Retinal Stimulation Therapy for Age-Related Macular Degeneration. Shinoda, Kei; Imamura, Yutaka; Matsuda, Sayaka; Seki, Maiko; Uchida, Atsuro; Grossman, Terry; Tsubota, Kazuo // Open Ophthalmology Journal;2008, Vol. 2, p132 

    This reports the preliminary outcome of a transpalpebral electrical retinal stimulation therapy for age-related macular degeneration (ARMD). Twenty-one patients consisting of 16 with wet-type (Group-W) and 5 with dry-type (Group-D) ARMD with a mean age of 73.9 ± 9.5 years (range 51 to 85...

  • Recurrence of Diabetic Macular Edema After Intravitreous Injection of Triamcinolone Following Vitrectomy. Yuka Shimonagano; Norihito Doi; Yoshihiro Noda; Akinori Uemura; Taiji Sakamoto // Japanese Journal of Ophthalmology;Jul2007, Vol. 51 Issue 4, p278 

    Abstract Purpose  To evaluate the effects of intravitreous triamcinolone acetonide (TA) after pars plana vitrectomy (PPV) for diabetic macular edema (DME). Methods  We studied a prospective interventional case series. TA was injected intravitreously after PPV in 28 eyes (PPV+TA...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics